Historical record - last NADAC publication: 8/23/2023
Product Information
SUMATRIPTAN-NAPROXEN 85-500 MG is a generic product labeled by Currax Pharmaceuticals LLC, priced at $17.8743 per EA under NDC 44183085009. Its NADAC has been published 272 times since Jul 18, 2018.
Strength
500; 85 mg/1; mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
44183085009
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021926On Market Since
5/14/2015
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has been published 272 times since Jul 18, 2018, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.8743 per EA |
|---|---|
| All-time high | $64.2190 (Nov 14, 2018) |
| All-time low | $14.7549 (Jan 18, 2023) |
| Median price | $32.2535 |
| Average price | $34.3990 |
| Largest weekly change | +47.6% (May 18, 2022) |
| Weeks tracked | 272 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the sumatriptan succinate and naproxen sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SUMATRIPTAN-NAPROXEN 85-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN-NAPROXEN 85-500 MG, manufactured by Currax Pharmaceuticals LLC, is $17.8743 per EA (NDC 44183085009), effective Sep 27, 2023.
How has the price of SUMATRIPTAN-NAPROXEN 85-500 MG changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has declined 63.2%. It has been tracked across 272 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN-NAPROXEN 85-500 MG?
Since Jul 18, 2018, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has ranged from a low of $14.7549 (Jan 18, 2023) to a high of $64.2190 (Nov 14, 2018), with a median of $32.2535 per EA.
Are there cheaper alternatives to SUMATRIPTAN-NAPROXEN 85-500 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SUMATRIPTAN-NAPROXEN 85-500 MG, so no direct lower-cost alternative is listed.
Who manufactures SUMATRIPTAN-NAPROXEN 85-500 MG?
SUMATRIPTAN-NAPROXEN 85-500 MG (NDC 44183085009) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification